Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_assertion type Assertion NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_head.
- NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_assertion description "[These butyrylcholinesterase activities do not behave as independent risk factors for metabolic syndrome, but can be considered as secondary markers for this syndrome in obese individuals with the CHE2 C5- phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_provenance.
- NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_assertion evidence source_evidence_literature NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_provenance.
- NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_assertion SIO_000772 15843232 NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_provenance.
- NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_assertion wasDerivedFrom befree-20150227 NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_provenance.
- NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_assertion wasGeneratedBy ECO_0000203 NP259902.RApKnSz50HrUlkKCVoQFVyk27rnb_GBycK7gFndEjfSwQ130_provenance.